VEXT — Vext Science Cashflow Statement
0.000.00%
Last trade - 00:00- CA$60.14m
- CA$107.60m
- $34.81m
- 47
- 65
- 42
- 50
Annual cashflow statement for Vext Science, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2019 December 31st | 2020 December 31st | 2021 December 31st | C2022 December 31st | 2023 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | 2.79 | 2.13 | 4.99 | 10.9 | 4.4 |
| Depreciation | |||||
| Amortisation | |||||
| Deferred Taxes | |||||
| Non-Cash Items | 0.351 | 1.39 | 3.31 | -0.233 | -13.6 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -4.64 | -3.07 | -1.74 | -7.18 | 7.04 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Other Assets | |||||
| Change in Accounts Payable | |||||
| Change in Accrued Expenses | |||||
| Change in Payable / Accrued Expenses | |||||
| Cash from Operating Activities | -0.393 | 3.1 | 11.7 | 5.72 | 4.42 |
| Capital Expenditures | -5.26 | -4.06 | -18.8 | -8.86 | -2.74 |
| Purchase of Fixed Assets | |||||
| Other Investing Cash Flow Items | -0.147 | -8.84 | -8.31 | -21.5 | -2.09 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Sale of Fixed Assets | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -5.41 | -12.9 | -27.1 | -30.3 | -4.82 |
| Financing Cash Flow Items | 0.145 | -0.5 | -1.5 | -1.63 | -1.03 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 9.7 | 4.26 | 20.1 | 24.1 | 3.19 |
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 3.9 | -5.55 | 4.72 | -0.533 | 2.79 |